This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
TERT genetic variability and telomere length as factors affecting survival and risk in acute myeloid leukaemia
Scientific Reports Open Access 02 December 2021
-
Telomerase reverse transcriptase gene amplification in hematological malignancies
Egyptian Journal of Medical Human Genetics Open Access 29 November 2019
-
Short telomere length and its correlation with gene mutations in myelodysplastic syndrome
Journal of Hematology & Oncology Open Access 28 July 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Calado RT, Regal JA, Hills M, Yewdell WT, Dalmazzo LF, Zago MA et al. Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia. Proc Natl Acad Sci USA 2009; 106: 1187–1192.
Calado RT, Young NS . Telomere diseases. N Engl J Med 2009; 361: 2353–2365.
Swiggers SJ, Kuijpers MA, de Cort MJ, Beverloo HB, Zijlmans JM . Critically short telomeres in acute myeloid leukemia with loss or gain of parts of chromosomes. Genes Chromosomes Cancer 2006; 45: 247–256.
Hartmann U, Brummendorf TH, Balabanov S, Thiede C, Illme T, Schaich M . Telomere length and hTERT expression in patients with acute myeloid leukemia correlates with chromosomal abnormalities. Haematologica 2005; 90: 307–316.
Xin ZT, Beauchamp AD, Calado RT, Bradford JW, Regal JA, Shenoy A et al. Functional characterization of natural telomerase mutations found in patients with hematologic disorders. Blood 2007; 109: 524–532.
Alder JK, Chen JJ, Lancaster L, Danoff S, Su SC, Cogan JD et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc Natl Acad Sci USA 2008; 105: 13051–13056.
Hartmann D, Srivastava U, Thaler M, Kleinhans KN, N'Kontchou G, Scheffold A et al. Telomerase gene mutations are associated with cirrhosis formation. Hepatology 2011; 53: 1608–1617.
Calado RT, Brudno J, Mehta P, Kovacs JJ, Wu C, Zago MA et al. Constitutional telomerase mutations are genetic risk factors for cirrhosis. Hepatology 2011; 53: 1600–1607.
Yamada O, Oshimi K, Motoji T, Mizoguchi H . Telomeric DNA in normal and leukemic blood cells. J Clin Invest 1995; 95: 1117–1123.
Balgobind BV, Hollink IH, Arentsen-Peters ST, Zimmermann M, Harbott J, Beverloo HB et al. Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia. Haematologica 2011; 96: 1478–1487.
Hemann MT, Strong MA, Hao LY, Greider CW . The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 2001; 107: 67–77.
Baird DM, Rowson J, Wynford-Thomas D, Kipling D . Extensive allelic variation and ultrashort telomeres in senescent human cells. Nat Genet 2003; 33: 203–207.
Hollink IH, van den Heuvel-Eibrink MM, Arentsen-Peters ST, Pratcorona M, Abbas S, Kuipers JE et al. NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern. Blood 2011; 118: 3645–3656.
Roos G, Krober A, Grabowski P, Kienle D, Buhler A, Dohner H et al. Short telomeres are associated with genetic complexity, high-risk genomic aberrations, and short survival in chronic lymphocytic leukemia. Blood 2008; 111: 2246–2252.
Brummendorf TH, Holyoake TL, Rufer N, Barnett MJ, Schulzer M, Eaves CJ et al. Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry. Blood 2000; 95: 1883–1890.
Acknowledgements
AMA was supported by the KiKa Foundation, Amstelveen, The Netherlands, the René Vogels Foundation, Oirschot, and Erasmus Trustfonds, Rotterdam, The Netherlands. This research was supported in part by the National Institutes of Health (NHLBI) Intramural Research Program.
Author contributions
AMA, RTC, SK, NSY, CMZ, RP, VHJV, MMHE conceived and designed the experiments; AMA, SK performed the experiments; AMA, RTC, CMZ, CW, EC, MZ, RP, VHJV, MMHE analyzed the data; AMA, RTC, NSY, CMZ, CW, SK, EC, AB, KG, GJLK, VH, TWK, DR, JT, MZ, RP, VHJV, MMHE contributed reagents, materials and analysis tools and approved the final version of the paper; AMA, RTC, NSY, VHJV, MMHE wrote the paper.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Leukemia website
Supplementary information
Rights and permissions
About this article
Cite this article
Aalbers, A., Calado, R., Young, N. et al. Telomere length and telomerase complex mutations in pediatric acute myeloid leukemia. Leukemia 27, 1786–1789 (2013). https://doi.org/10.1038/leu.2013.57
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2013.57
This article is cited by
-
Clinical and functional characterization of telomerase variants in patients with pediatric acute myeloid leukemia/myelodysplastic syndrome
Leukemia (2021)
-
TERT genetic variability and telomere length as factors affecting survival and risk in acute myeloid leukaemia
Scientific Reports (2021)
-
Telomerase reverse transcriptase gene amplification in hematological malignancies
Egyptian Journal of Medical Human Genetics (2019)
-
Short telomere length and its correlation with gene mutations in myelodysplastic syndrome
Journal of Hematology & Oncology (2016)
-
Telomerase reverse transcriptase (TERT) A1062T mutation as a prognostic factor in Egyptian patients with acute myeloid leukemia (AML)
Medical Oncology (2014)